#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Enteritis Pericarditis Wiskott-Aldrich syndrome Rheumatoid arthritis Infertility male Oesophageal adenocarcinoma stage III Frostbite Bone marrow disorder Rett syndrome Leukodystrophy Facioscapulohumeral muscular dystrophy Choroid melanoma Congenital growth hormone deficiency Ovarian cancer Interstitial lung disease More trials…

    Learn about Rare Diseases

    Leukoencephalopathy – Basic Information Uterine leiomyosarcoma – Diagnostics Mucopolysaccharidosis III – Trials in Disease Combined immunodeficiency – Trials in Disease Retinoblastoma – Treatment Hereditary hypophosphataemic rickets – Diagnostics Mucous membrane pemphigoid – Trials in Disease Noonan syndrome Mucopolysaccharidosis II Hepatic angiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mercaptopurine Monohydrate Elenestinib Phosphate Olopatadine Sym023 Efepoetin Alfa Rosuvastatin Zinc Efgartigimod Alfa Iclepertin Nido-361 Olopatadine Hydrochloride Tigulixostat Fezolinetant Cladribine 13N-AMMONIA Aspartic Acid Patritumab Deruxtecan Belumosudil Mesilate Sorafenib CHLOROQUINE PHOSPHATE Efinopegdutide More therapies…

    Learn about Your Condition

    Ventricular extrasystoles Respiratory distress Chronic kidney disease Hip arthroplasty Vulval cancer Benign renal neoplasm Vulvovaginal dryness Dementia Alzheimer's type Basal cell carcinoma Erythema migrans Salivary gland cancer Alpha-1 antitrypsin deficiency Systemic candida Hypocalcaemia Osteotomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Osteo-Medic s.c. Artur Racewicz, Jerzy Supronik

Osteo-Medic s.c. Artur Racewicz, Jerzy Supronik

ul. Wiejska 81, Bialystok, 15-351, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    Investigated Drugs:
    • Bio89-100
    • Simvastatin
    Austria Belgium Bulgaria Czechia France Germany +5

  • Study on How Insulin Icodec and Semaglutide Help Control Blood Sugar in Patients with Type 2 Diabetes

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Insulin Icodec
    • Semaglutide
    Czechia Poland

  • Study on the Effects and Safety of ODM-111 and Paracetamol for Chronic Knee Pain in Osteoarthritis Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Arthralgia
    Investigated Drugs:
    • Odm-111
    • Paracetamol
    Czechia Denmark Germany Poland Spain

  • Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    • Pain
    Investigated Drugs:
    • Odm-111
    • Paracetamol
    Bulgaria Czechia Germany Hungary Poland

  • Study on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Bimekizumab
    • Risankizumab
    Bulgaria Czechia Germany Hungary Poland Spain

  • Study on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis

    Not recruiting

    3 1
    Investigated Drugs:
    • Guselkumab
    Bulgaria Croatia Czechia Estonia Germany Greece +8

  • Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Risankizumab
    Belgium Bulgaria Croatia Czechia Denmark Estonia +11
Previous Page
1 … 3 4 5

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!